Multi-user Equipment approved in grant 2013/07600-3: citometer

• Grant number: 22/03494-3
• Support Opportunities: Multi-user Equipment Program
• Start date: May 01, 2022
• End date: April 30, 2029
• Field of knowledge: Biological Sciences - Biophysics - Cellular Biophysics
• Principal Investigator: Glaucius Oliva
• Grantee: Glaucius Oliva
• Host Institution: Instituto de Física de São Carlos (IFSC). Universidade de São Paulo (USP). São Carlos , SP, Brazil
• Associated research grant: 13/07600-3 - CIBFar - Center for Innovation in Biodiversity and Drug Discovery, AP.CEPID
• EMU web page: Página do Equipamento Multiusuário não informada
• Type of equipment: Caracterização e Análises de Amostras - Proteínas/Ácidos nuclêicos - PCR
• Manufacturer: Fabricante não informado
• Model: Modelo não informado

Abstract

The Center for Research and Innovation in Biodiversity and Drug Discovery (CIBFar) is a joint initiative resulting from existing collaborativeresearch projects, including the Physics Institute of São Carlos (IFSC) and the School of Pharmaceutical Sciences of RibeiraoPreto at the University of São Paulo (USP), the Institute of Chemistry at the State University of São Paulo (UNESP), theInstitute of Chemistry at the State University of Campinas (UNICAMP), and the Department of Chemistry at the FederalUniversity of São Carlos (UFSCar). The major goals of this Center are to perform basic and applied science and to developtechnologies, such as in vitro and in vivo biological and pharmacological evaluations, for all areas of biodiversity and drugdiscovery that rely on state-of-the-art methods in medicinal chemistry, natural products chemistry, synthetic organic chemistry,and molecular and structural biology. Strategic partnerships with the private sector are always sought, particularly with nationaland international pharmaceutical companies and research institutes within the health sector. The ultimate goals are thedevelopment of clinical candidates for tropical infectious diseases, cancer and central nervous system disorders and thedevelopment of new synthetic routes to generic drugs. On the educational front, the Center also relies on the considerableexperience that has been acquired over the last eleven years from our previous CEPID-FAPESP. Intensive work has been doneon outreach programs focused on science education from elementary school to high school. CIBFar has the benefit of joiningresearch groups in a modern multidisciplinary setting while also providing access to a well-established infrastructure withextensive experience in the areas of technical, financial, educational, technological and executive management. (AU)